John R. Middleton

Prof. Dr. John R. Middleton


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2013 in Journal of Dairy Science
Verified
Journal Article
Closed access
PDF file
WCW.G. Chamberlin
W.G. Chamberlin
JMJohn R. Middleton
John R. Middleton
JSJ.N. Spain
J.N. Spain
GJG.C. Johnson
G.C. Johnson
MEM.R. Ellersieck
M.R. Ellersieck
PPPatrick ODONGO PITHUA
Patrick ODONGO PITHUA
A study was conducted to evaluate the potential association between Ca status at calving and postpartum energy balance, liver lipid infiltration, disease occurrence, milk yield and quality parameters, and fertility in Holstein cows. One hundred cows were assigned to 1 of 2 groups based on whole-blood ionized Ca concentration ([iCa]) on the day of calving [d 0; hypocalcemic [iCa] <1.0 mmol/L (n=51); normocalcemic [iCa] ≥ 1.0 mmol/L (n=49)]. Cows were blocked based on calving date and parity. Blood samples were collected approximately 14 d from expected calving date (d -14), the day of calving (d 0), and on d 3, 7, 14, 21, and 35 postpartum for measurement of plasma nonesterified fatty acid, iCa, total Ca, glucose, and total and direct bilirubin concentrations, and plasma aspartate aminotransferase and gamma glutamyl transferase activities. Liver biopsies were obtained from a subset of cows on d 0, 7, and 35 for quantification of lipid content. Milk samples were collected on d 3, 7, 14, 21, and 35 postpartum for measurement of somatic cell count and percentages of protein, fat, and solids-not-fat. Data for peak test-day milk yield, services per conception, and days open were obtained from Dairy Herd Improvement Association herd records. Disease occurrence was determined based on herd treatment records. Hypocalcemic cows had significantly higher nonesterified fatty acids on d 0. Hypocalcemic cows also had significantly more lipid in hepatocytes on d 7 and 35 postpartum. However, no statistically significant differences were observed between groups for plasma aspartate aminotransferase and gamma glutamyl transferase activities or total and direct bilirubin concentrations. Milk protein percentage was lower in hypocalcemic cows on d 21 and 35. However other milk quality variables (somatic cell count, milk fat percentage, and solids-not-fat) and milk yield variables (peak test-day milk yield and 305-d mature-equivalent 4% fat-corrected milk yield) did not differ between groups. No differences were observed between groups in the occurrence of clinical mastitis, ketosis, displaced abomasum, dystocia, retained placenta, metritis, or fertility measures (percentage cycling at 50-60 d postpartum, services per conception, or days open). These data suggest that early lactation fatty acid metabolism differs between cows with subclinical hypocalcemia and their normocalcemic counterparts.

1 August 2014 in Journal of Dairy Science
Verified
Journal Article
Closed access
PFP.R. Fry
P.R. Fry
JMJohn R. Middleton
John R. Middleton
SDS. Dufour
S. Dufour
JPJ. Perry
J. Perry
DSD. Scholl
D. Scholl
IDI. Dohoo
I. Dohoo
This study was conducted to evaluate the association between subclinical intramammary infection (IMI) with coagulase-negative staphylococci (CNS), mammary quarter milk somatic cell count (SCC), and persistence of IMI in dairy cattle. Convenience samples of CNS isolates harvested from milk samples of subclinically infected mammary quarters collected between 4 and 2wk before drying-off, between 2wk before drying-off and the day of drying-off, within 24h after calving, between 1 and 2wk after calving, and during lactation were evaluated. Isolates were obtained from the Canadian Bovine Mastitis Research Network culture bank and were identified to the species level using rpoB gene sequencing. Cow and quarter-level data were obtained from the Canadian Bovine Mastitis Research Network database and used for statistical analyses. In addition, for mammary quarters that had more than one isolation of the same CNS species at different time points, the isolates were evaluated using pulsed-field gel electrophoresis to identify persistent IMI. Milk SCC was compared between mammary quarters infected with different CNS species and to a cohort of uninfected mammary quarters. A total of 877 isolates from 643 mammary quarters of 555 cows on 89 Canadian dairy farms were identified to the species level. Twenty different species were identified, with Staphylococcus chromogenes being the most common species identified (48% of isolates), followed by Staphylococcus simulans (19%) and Staphylococcus xylosus (10%). Of the 20 species identified, only 9 species were found in persistently infected quarters. Milk SCC was significantly higher in the CNS-infected mammary quarters than in the uninfected control quarters for 8 of the 20 species studied. Also, mean SCC differed significantly between mammary quarters infected with different CNS species. Within a given species, a high degree of variability was noted in milk SCC. These data corroborate recent data from Europe with regard to the predominance of certain species of CNS (e.g., Staph. chromogenes). In addition, some species of CNS appear to have a greater effect on milk SCC. Finally, some CNS species are associated with persistent IMI suggesting that some species (e.g., Staph. chromogenes and Staph. simulans) are better host-adapted, whereas others may have an environmental reservoir.

1 August 2008 in Expert Review of Vaccines
Verified
Journal Article
Closed access
JMJohn R. Middleton
John R. Middleton
Staphylococcus aureus is an important cause of nosocomial and community-acquired infections in humans and animals, as well as mastitis in dairy cattle. Methicillin-resistant S. aureus is increasingly recognized as a cause of staphylococcal infection and, therefore, immunotherapeutics have received new interest in both human and veterinary medicine. Vaccines aimed at preventing S. aureus infection in humans and mastitis in dairy cattle have been studied for many years. While some formulations have shown promise in ameliorating clinical disease, few, if any, of the S. aureus vaccines developed have adequately prevented new infection. The antigens targeted by S. aureus vaccines and potential reasons for the lack of success of vaccination against S. aureus are reviewed in this article.

22 September 2005 in Journal of Dairy Research
Verified
Journal Article
Closed access
PDF file
JMJohn R. Middleton
John R. Middleton
JMJianneng Ma
Jianneng Ma
CRCarol L Rinehart
Carol L Rinehart
VTVeronica N Taylor
Veronica N Taylor
CLChristopher D Luby
Christopher D Luby
BSBarry J Steevens
Barry J Steevens
The objective was to compare the efficacy of two experimental Staphylococcus aureus mastitis bacterins and a currently marketed five-isolate-based Staph. aureus bacterin (Lysigin™, Boehringer Ingelheim Vetmedica, Inc.) with unvaccinated controls. Forty-seven Holstein-Friesian heifers were randomly assigned to one of four groups such that Group 1 (n=11) received a three-isolate experimental bacterin, Group 2 (n=11) received a five-isolate experimental bacterin, Group 3 (n=14) received Lysigin, and Group 4 (n=11) served as unvaccinated controls. Vaccinations were administered twice 28 d apart in late gestation. All groups were challenged with a heterologous strain of Staph. aureus (ATCC 29740) on days 6, 7, and 8 of lactation. Mastitis score, somatic cell count (SCC), milk culture yield, and total daily milk yield data were collected before and after challenge. All 47 cattle developed a Staph. aureus IMI post-challenge with three animals in Group 1 and one animal in Group 3 clearing their Staph. aureus IMI by the end of the study. However, there was no evidence of a difference between vaccinates and control with regard to Staph. aureus clearance rates post-challenge (P[ges ]0·214). Cattle vaccinated with Lysigin had a lower mean duration of clinical mastitis and lower total mastitis score post-challenge than controls (P=0·045 and P=0·046, respectively). Overall, there was no evidence that any of the vaccinated groups had a lower mean SCC than control (P[ges ]0·148) for the tested study days. Likewise there was no evidence that vaccinates had greater milk yield than controls post-challenge (P=0·617). Hence, there was no evidence that the vaccines reliably prevented Staph. aureus IMI, but Lysigin showed benefit in reducing the clinical severity and duration of clinical disease post-challenge. Neither of the experimental bacterins appeared to perform better than Lysigin.

1 June 2005 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
PDF file
JMJohn R. Middleton
John R. Middleton
WFWilliam H. Fales
William H. Fales
CLChristopher D. Luby
Christopher D. Luby
JOJ. Lindsay Oaks
J. Lindsay Oaks
SSSusan Sanchez
Susan Sanchez
FHFaye Hartmann
Faye Hartmann
Staphylococcus aureusisolates (n= 70) from 65 patients (36 canine, 18 equine, 7 bovine, 2 avian, and 2 feline) at seven veterinary teaching hospitals in the United States were studied. The majority of patients (83%) with anS. aureusinfection were canine and equine, but this may have reflected a sample bias based on clinic case loads and diagnostic lab submissions at the participating institutions. Fourteen percent of patients with anS. aureusinfection were infected with a methicillin-resistantS. aureus(MRSA) isolate. Six of seven institutions had at least one MRSA infection during the study. Pulsed-field gel electrophoresis on 63 of the 70 isolates yielded 58 unique strains ofS. aureus. None of the strain types of the MRSA isolates matched each other or the type of any otherS. aureusisolate. The proportions of patients infected with an MRSA isolate were not significantly different between institutions or animal species (P≥ 0.222). Methicillin-resistantS. aureusisolates in this study seemed to be community acquired rather than hospital acquired.

19 December 2014 in Journal of Mammary Gland Biology and Neoplasia
Verified
Journal Article
Closed access
PDF file
JMJohn R. Middleton
John R. Middleton
ASAnne Saeman
Anne Saeman
LFLarry K. Fox
Larry K. Fox
JLJason Lombard
Jason Lombard
JHJoe S. Hogan
Joe S. Hogan
KSK. Larry Smith
K. Larry Smith